For example, the anti-lymphoma function of CAR-NKT cells can be improved by inducing more translation and expression of CD1d on lymphoma cells and CLL-B cells, which is mediated by all-trans retinoic acid (ATRA). This evidence concerns the gene CD1D and lymphoma.